Corvus Pharmaceuticals Inc (CRVS)
Investing Cash Flow
-$142.55M
TTM · Period ending: · USD
CRVS Investing Cash Flow
Latest reported-$142.55Mperiod ending
Latest reported-$142.55Mperiod ending
CRVS TTM Cash from Investing (-$92.03M → -$142.55M)
TTM investing cash flow
High-resolution chart · PNG
CRVS investing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Investing Cash Flow (USD) |
|---|---|
| -142,549,000 | |
| -156,885,000 | |
| -7,796,000 | |
| -24,759,000 | |
| -26,031,000 | |
| -23,234,000 | |
| -27,484,000 | |
| -23,719,000 | |
| -2,283,000 | |
| 10,932,000 | |
| 15,541,000 | |
| 13,977,000 | |
| -529,000 | |
| 6,900,000 | |
| -23,276,000 | |
| -21,393,000 | |
| -20,962,000 | |
| -8,860,000 | |
| 21,560,000 | |
| 24,022,000 | |
| 30,490,000 | |
| 21,918,000 | |
| 44,769,000 | |
| 48,901,000 | |
| 28,437,000 | |
| 22,183,000 | |
| 3,255,000 | |
| 5,194,000 | |
| 39,029,000 | |
| -25,043,000 | |
| -30,192,000 | |
| -26,053,000 | |
| -28,706,000 | |
| 70,269,000 | |
| 84,826,000 | |
| 83,031,000 | |
| 70,292,000 | |
| 34,368,000 | |
| -42,556,000 | |
| -122,261,000 | |
| -124,785,000 | |
| -150,455,000 | |
| -92,032,000 | |
| -21,205,000 |